Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Catheter Tissue Contact in PFA

NCT: NCT07721948 · NOT_YET_RECRUITING

NCT IDNCT07721948
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2028-09-01
SponsorUniversity Medical Centre Ljubljana (OTHER)
First posted
Last updated

Brief Summary

Pulmonary vein isolation remains the cornerstone of invasive treatment for atrial fibrlllation. Despite recent technological advances in the field of pulsed field ablation (PFA) pulmonary vein isolation durability and arrhythmia free success rates remain approximately at the level of previous years and the radiofrequency ablation era. Isolation durability during PFA procedures might be enhanced by: 1. Intraprocedural monitoring contact of catheter electrode to atrial tissue. 2. Intraprocedural assessment of the transmurality of irreversible electroporation lesion. The aim of our study is to use intracardiac electrogram (iEGM) based analysis for assessment of catheter-tissue contact and PFA lesion durability.

Frequently Asked Questions

What is Assessment of Catheter Tissue Contact in PFA?

Assessment of Catheter Tissue Contact in PFA is a clinical trial registered under NCT07721948. Current status: NOT_YET_RECRUITING.

What is the status of NCT07721948?

The current status of NCT07721948 (Assessment of Catheter Tissue Contact in PFA) is: NOT_YET_RECRUITING.

When did Assessment of Catheter Tissue Contact in PFA start?

Assessment of Catheter Tissue Contact in PFA started on 2026-09-01.

Related Devices

PMA P230017Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationMedtronic, Inc. PMA P240013Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationMedtronic, Inc. PMA P240044Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationKardium, Inc. PMA P250022Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationABBOTT MEDICAL K183547Marinr Steerable Intracardiac Electrode Catheter, StableMapr Steerable Intracardiac Electrode Catheter, Torqr Intracardiac Electrode Catheter, Soloist Intracardiac Electrode CatheterMedtronic

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑